Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0001234066-05-000003

Options or other derivatives

  • President & CEO acquired 10,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
HARRIS ROBERT B President & CEO 2005-01-03 Grant or award · Options +10,000 $6.00 $60,000 119,460 D
Loading xslF345X02/primary_doc.xml…